Epigenetic Modifiers in Cancer Metastasis

被引:2
|
作者
Hu, Die [1 ,2 ,3 ]
Zhao, Tianci [4 ,5 ]
Xu, Chenxing [3 ]
Pan, Xinyi [3 ]
Zhou, Zhengyu [1 ,2 ,6 ]
Wang, Shengjie [1 ,2 ,3 ,6 ]
机构
[1] Nanjing Med Univ, Kangda Coll, Key Lab Mol Genet, Suzhou 215123, Peoples R China
[2] Soochow Univ, Suzhou Med Coll, Key Lab Mol Genet, Suzhou 215123, Peoples R China
[3] Nanjing Med Univ, Kangda Coll, Dept Basic Med, Lianyungang 222000, Peoples R China
[4] China Med Univ, Minist Publ Hlth, Key Lab Cell Biol, Shenyang 110122, Peoples R China
[5] China Med Univ, Minist Educ, Key Lab Med Cell Biol, Shenyang 110122, Peoples R China
[6] Soochow Univ, Suzhou Med Coll, Lab Anim Ctr, Suzhou 215123, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
epigenetics; DNA methylation; histone methylation; non-coding RNAs; metastasis; ENHANCER REPROGRAMMING PROMOTES; BREAST-CANCER; NONCODING RNA; LUNG METASTASIS; MESSENGER-RNA; LIVER-DISEASE; CELL; METHYLATION; GROWTH; CHROMATIN;
D O I
10.3390/biom14080916
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Metastasis is the primary cause of cancer-related death, with the dissemination and colonization of primary tumor cells at the metastatic site facilitated by various molecules and complex pathways. Understanding the biological mechanisms underlying the metastatic process is critical for the development of effective interventions. Several epigenetic modifications have been identified that play critical roles in regulating cancer metastasis. This review aims to provide a comprehensive summary of recent advances in understanding the role of epigenetic modifiers, including histone modifications, DNA methylation, non-coding RNAs, enhancer reprogramming, chromatin accessibility, and N6-methyladenosine, in metastasis-associated processes, such as epithelial-mesenchymal transition (EMT), cancer cell migration, and invasion. In particular, this review provides a detailed and in-depth description of the role of crosstalk between epigenetic regulators in tumor metastasis. Additionally, we explored the potential and limitations of epigenetics-related target molecules in the diagnosis, treatment, and prognosis of cancer metastasis.
引用
收藏
页数:23
相关论文
共 50 条
  • [11] Epigenetic modulators, modifiers and mediators in cancer aetiology and progression
    Andrew P. Feinberg
    Michael A. Koldobskiy
    Anita Göndör
    Nature Reviews Genetics, 2016, 17 : 284 - 299
  • [12] Epigenetic basis and targeting of cancer metastasis
    Banerjee, Rakesh
    Smith, Jim
    Eccles, Michael R.
    Weeks, Robert J.
    Chatterjee, Aniruddha
    TRENDS IN CANCER, 2022, 8 (03): : 226 - 241
  • [13] Epigenetic Alterations in Pancreatic Cancer Metastasis
    Wang, Sarah S.
    Xu, Jihao
    Ji, Keely Y.
    Hwang, Chang-Il
    BIOMOLECULES, 2021, 11 (08)
  • [14] Epigenetic drivers of tumourigenesis and cancer metastasis
    Chatterjee, Aniruddha
    Rodger, Euan J.
    Eccles, Michael R.
    SEMINARS IN CANCER BIOLOGY, 2018, 51 : 149 - 159
  • [15] Epigenetic control of pancreatic cancer metastasis
    Lukas Krauß
    Carolin Schneider
    Elisabeth Hessmann
    Dieter Saur
    Günter Schneider
    Cancer and Metastasis Reviews, 2023, 42 (4) : 1113 - 1131
  • [16] Epigenetic control of pancreatic cancer metastasis
    Krauss, Lukas
    Schneider, Carolin
    Hessmann, Elisabeth
    Saur, Dieter
    Schneider, Guenter
    CANCER AND METASTASIS REVIEWS, 2023, 42 (04) : 1113 - 1131
  • [17] Epigenetic regulation of breast cancer metastasis
    Thakur, Chitra
    Qiu, Yiran
    Pawar, Aashna
    Chen, Fei
    CANCER AND METASTASIS REVIEWS, 2024, 43 (02) : 597 - 619
  • [18] Targeting Epigenetic Modifiers: Promising Strategies for Cancer Therapy and Beyond
    Chanchal, Dilip Kumar
    Porwal, Prateek
    Mittal, Nidhi
    CURRENT DRUG THERAPY, 2025, 20 (01) : 33 - 44
  • [19] The roles of chromatin-remodelers and epigenetic modifiers in kidney cancer
    Liao, Lili
    Testa, Joseph R.
    Yang, Haifeng
    CANCER GENETICS, 2015, 208 (05) : 206 - 214
  • [20] Using epigenetic modifiers to target cancer stem cell immunoevasion
    Galassi, Claudia
    Vitale, Ilio
    Galluzzi, Lorenzo
    CANCER CELL, 2021, 39 (12) : 1573 - 1575